Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiaozhenjiedu formula for EGFR-TKI-related skin rash in lung cancer
ChiCTR1800020249Phase 2Not yet recruiting
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Jan 2018
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Xiaozhenjiedu formula, erythromycin in papulopustular eruption, bronchial carcinoma, sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Planned start Jan 2018; status: not yet recruiting.
02
Drugs
Xiaozhenjiedu formulaerythromycin
03
Conditions
papulopustular eruptionbronchial carcinoma
Beyond the preview
Go deeper on ChiCTR1800020249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800020249.